128595-01-7

Basic information

• Product Name: 2,5-Pyrrolidinedione, 1-[[[(4-methylphenyl)methoxy]carbonyl]oxy]-
• CAS NO: 128595-01-7
• Molecular Formula: C13H13NO5
• Molecular Weight: 263.25
• Mol File: 128595-01-7.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 2,5-Pyrrolidinedione, 1-[[[(4-methylphenyl)methoxy]carbonyl]oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-Pyrrolidinedione, 1-[[[(4-methylphenyl)methoxy]carbonyl]oxy]-(128595-01-7)
• EPA Substance Registry System: 2,5-Pyrrolidinedione, 1-[[[(4-methylphenyl)methoxy]carbonyl]oxy]-(128595-01-7)

Safety Data

• Hazardous Substances Data: 128595-01-7(Hazardous Substances Data)

Upstream product

• 74124-79-1 di(succinimido) carbonate 
• 589-18-4 4-Methylbenzyl alcohol 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 

Downstream Products

• 802911-36-0 (2R,3R)-3-Hydroxy-2-(4-methyl-benzyloxycarbonylamino)-butyric acid 
• 859235-80-6 (2R,3R)-3-[(9H-Fluoren-9-ylmethoxycarbonyl)-methyl-amino]-2-(4-methyl-benzyloxycarbonylamino)-butyric acid methyl ester 
• 859235-77-1 (2R,3R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-(4-methyl-benzyloxycarbonylamino)-butyric acid methyl ester 
• 859235-81-7 MeZ-(R)-Asn-OH 

Relevant articles and documents

Imidazopyridine derivatives and the use thereof as medicament

The present invention relates to imidazopyridines of formula A processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with NR2B

3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS

Disclosed are chemical entities of Formula (I), wherein R1 and Z are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of Formula (I), and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of Formula (I).

N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists

Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.